More than 1,000 genes may serve as possible treatment targets for individuals with kidney disease, according to a new study, ...

More than 35 million people in the U.S. have chronic kidney disease (CKD), a condition in which the kidneys are damaged and ...

Yo-Yo Dieting May Significantly Increase Kidney Disease Risk in People With Type 1 Diabetes Feb. 4, 2025 — Body-weight cycling ... 2024 — A team developed a human iPS cell-derived kidney ...

Alternatively, it may affect only a certain part of the body, such as the face, back, or arm. People with chronic kidney disease may not experience any skin symptoms, or they may have a rash ...

Nearly 10% of people live with chronic kidney disease—in other words ... sex, education, body mass index or cardio-vascular health. They also demonstrated brain atrophy—that is, shrinkage ...

These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for folks battling chronic kidney disease, new ...

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the US Food and Drug Administration to reduce certain risks associated with ...

Kidney disease, leading to kidney failure, afflicts disproportionately more black people than white people. Thus, there is a ...

Body weight cycling, also known as “yo-yo dieting,” is associated with a 25%-36% increased risk for diabetic kidney disease ...

In the assessment done by DelveInsight, the estimated total diagnosed prevalent cases of chronic kidney disease in the US ...

The FDA approval of Ozempic to treat chronic kidney disease highlights a growing body of evidence showing that GLP-1 drugs could help treat other health conditions aside from obesity and type 2 ...

Elevated serum fibroblast growth factor 23 levels at baseline are linked to a 29% increased risk for diabetic kidney disease, a recent observational study found.